4.6 Letter

Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic

Related references

Note: Only part of the references are listed.
Letter Dermatology

Should biologics for psoriasis be interrupted in the era of COVID-19?

Mark Lebwohl et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Review Medicine, Research & Experimental

A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases

Eleni Vangeli et al.

ADVANCES IN THERAPY (2015)

Article Rheumatology

Measures of Anxiety

Laura J. Julian

ARTHRITIS CARE & RESEARCH (2011)